AstraZeneca Breast-Cancer Drug Shown to Slow Tumor Progression
A new study showed Enhertu cut the risk of tumor progression by half for people with the most advanced form of the disease, offering the prospect of a new treatment for one of the most widely diagnosed cancers.
Jun. 6, 2022 at 1:51 p.m. ET by Denise Roland
Stock Indexes Rise After Weekly Loss
U.S. stock benchmarks moved higher, putting the Dow and S&P 500 on track to recover from a muted trading week that ended in losses.
Jun. 6, 2022 at 12:59 p.m. ET by Chelsey Dulaney
Amazon’s First Stock Split Since 1999 Takes Effect
The e-commerce giant’s 20-for-1 stock split went into effect Monday. The split will in part make the tech company’s share price more accessible, the company has said.
Jun. 6, 2022 at 12:37 p.m. ET by Allison Prang
Boris Johnson Faces No-Confidence Vote Over Lockdown Parties
A ballot was triggered by rebel lawmakers in the Conservative Party following a collapse in the U.K. prime minister’s poll ratings caused in part by parties in Downing Street during Covid-19 lockdowns.
Jun. 6, 2022 at 12:32 p.m. ET by Max Colchester
Musk Threatens to End Twitter Deal Over Data Request
Elon Musk accused Twitter of not complying with his request for data on the number of spam and fake accounts on the social-media platform. Twitter said it will continue to share information and intends to enforce the merge…
Jun. 6, 2022 at 12:26 p.m. ET by Will Feuer
Source: Marketwatch